Eurazeo related stories
All articles and analysis
Side Letter: CalPERS' competition, Eurazeo's Seoul, ideal portfolio constructionBuilding a PE team is typically done in secrecy. For CalPERS, the need for transparency around its directs programme has come back to bite it. Here’s today's brief, for our valued subscribers only.
Side Letter: Eurazeo's strip sale, Brookfield eyes secondaries, Arizona's shake-upGot a sizeable balance sheet and want to help your fundraise over the line? Use a secondaries 'strip sale'. Here’s today's brief, for our valued subscribers only.
Side Letter: Eurazeo's €1bn for growth, Vision Fund 2, secondaries' slow startEurazeo eyes Europe's unicorns; SoftBank ups stake in Vision Fund 2; and secondaries fundraising slows in H1. Here’s today's brief, for our valued subscribers only.
Eurazeo’s Morgon: ‘We have major ambitions for growth investing’The firm is targeting €1bn for its third Europe-focused growth fund, which it expects to launch as early as this year.
Eurazeo Capital closes fourth fund on €2.5bn targetThe firm raised about €700m in third-party capital for Eurazeo Capital IV, with the €1.8bn remainder coming from its balance sheet.
Eurazeo raises €700mThe global investment company closes fund at nearly 40 percent more than its predecessor.
French private equity: More than just looking for profitFour insiders explain how the country's private equity industry has shifted amid political and fiscal changes, and why sustainability has become a much bigger play.
GP stakes: Who's on the shopping list?PAI Partners, Affinity Equity Partners and Coller Capital are among the most suitable candidates for a GP stake investment, according to a report.
PEI 300 2019: Six firms making wavesThe firms from across the PEI 300 that hit the headlines - for good or bad - this year.
European VC closes on Silicon ValleyEurope has delivered 30 unicorns over the last decade and the region's tech ecosystem has blossomed to the best the industry has ever known.